MSC EVs in Dystrophic Epidermolysis Bullosa

Clinical trial NCT04173650 · RECRUITING

Trial details

NCT number: NCT04173650
Sponsor: Aegle Therapeutics
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Dystrophic Epidermolysis Bullosa

Start date: 2024-08-13
Primary completion: 2025-09-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.